Clinical Trial Update: Safety and Efficacy of Mutation-targeted Precision Genetic Therapy for Ataxia-Telangiectasia (A-T) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a mutation-targeted precision genetic therapy for Ataxia-telangiectasia (Phase 1/Phase 2), currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ataxia-telangiectasia

Snippet

Sponsor: Timothy Yu | Conditions: Ataxia Telangiectasia | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING